abstract |
The present invention relates to antibodies that bind CTGF. This antibody binds in part to the CTGF involved in biological activity, particularly associated with fibrosis. The invention also provides a method of using this antibody to treat CTGF associated diseases, including local and systemic fibrosis diseases including lung, liver, heart, skin, kidneys. |